VIVOS INC (RDGL) earnings
RDGL earnings moved a median of +0.12% by the close. Quarterly and annual RDGL reports and results, each read against the price at its own news timestamp. Back to the RDGL overview →
14 measured RDGL earnings events.
Where these RDGL earnings landedvs 14 measured RDGL earnings reactions
| Middle 50% of RDGL earnings reactions | -1.28% to +1.81% |
|---|---|
| Median reaction (to close) | +0.12% |
| Measured reactions | 14 |
Point-in-time · zero look-ahead
Half of the 14 RDGL earnings events with a measured close landed between -1.28% and +1.81%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q VIVOS INC For: Jun 30 | SEC filing · Form 10-Q | +1.89% | +4.33% | |
| Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update | Press release | +0.17% | +0.25% | |
| Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - Correction | Press release | — | -3.04% | |
| Form 10-Q VIVOS INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.35% | |
| Form 10-K VIVOS INC For: Dec 31 | SEC filing · Form 10-K | +0.75% | +1.21% | |
| Form 10-Q VIVOS INC For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.04% | |
| Form 10-Q VIVOS INC For: Jun 30 | SEC filing · Form 10-Q | -0.48% | -0.48% | |
| Form 10-Q VIVOS INC For: Mar 31 | SEC filing · Form 10-Q | -1.59% | -3.84% | |
| Form 10-K VIVOS INC For: Dec 31 | SEC filing · Form 10-K | — | +1.74% | |
| Form 10-Q VIVOS INC For: Sep 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q VIVOS INC For: Jun 30 | SEC filing · Form 10-Q | — | +1.90% | |
| Form 10-Q VIVOS INC For: Mar 31 | SEC filing · Form 10-Q | -0.98% | +14.94% | |
| Form 10-K VIVOS INC For: Dec 31 | SEC filing · Form 10-K | — | +1.83% | |
| Form 10-Q VIVOS INC For: Sep 30 | SEC filing · Form 10-Q | -0.17% | -12.05% |
Keep exploring
More RDGL: analyst actions → · SEC filings → · RDGL overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Acasti Pharma, Inc. (ACST) | 89 | 0.00% | 44% |
| Microbix Biosystems Inc (MBX_TSE) | 89 | 0.00% | 32% |
| AMBU A S UNSP/ADR (AMBBY) | 87 | 0.00% | 13% |
| INTERPACE BIOSCIENCES INC (IDXG) | 87 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.